Literature DB >> 16433712

Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria.

M Boronat1, V F Varillas, P Saavedra, V Suárez, E Bosch, A Carrillo, F J Nóvoa.   

Abstract

AIMS: To estimate the prevalence and the determinants of diabetes mellitus and impaired glucose regulation (IGR) in an adult Canarian population.
METHODS: Cross-sectional study. One thousand and thirty subjects aged 30-82 years were randomly selected. Participants completed a survey questionnaire and underwent blood pressure measurements, anthropometry, blood samples, and a 75-g standardized oral glucose tolerance test.
RESULTS: The age-standardized prevalence of diabetes was 15.8% (95% confidence interval: 11.8-19.8) in men and 10.6% (7.1-14.1) in women. Total prevalence was 13.2% (11.1-15.2). Among individuals with diabetes, 55.4% of men and 38.2% of women were not previously diagnosed. The age-standardized prevalences of impaired glucose tolerance and impaired fasting glycaemia were 11.4% (9.5-13.4) and 2.8% (1.8-3.8), respectively. In multivariate analyses, age, waist circumference, serum triglycerides, and familial history of diabetes were independently associated with diabetes in both sexes, while a value of C-reactive protein (CRP) >/= 1 mg/l showed an association with diabetes, but only in men. Age and triglycerides were related to impaired glucose regulation (IGR) in both sexes, waist circumference was related to IGR exclusively in men, and familial diabetes exclusively in women. Statistically significant interactions between gender and both CRP and triglycerides were found with respect to diabetes, and between gender and both waist circumference and triglycerides for IGR.
CONCLUSIONS: Compared with the rest of Spain, the prevalence of diabetes is moderately increased in this area of the Canary Islands. Along with other well-established risk factors, CRP was independently associated with diabetes, but only in the male population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433712     DOI: 10.1111/j.1464-5491.2005.01739.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study.

Authors:  A M Wägner; J C Wiebe; M Boronat; P Saavedra; D Marrero; F Varillas; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

2.  Impaired Fasting Glucose in Omani Adults with no Family History of Type 2 Diabetes.

Authors:  Sawsan Al-Sinani; Mohammed Al-Shafaee; Ali Al-Mamari; Nicolas Woodhouse; Omayma El-Shafie; Mohammed O Hassan; Said Al-Yahyaee; Sulayma Albarwani; Deepali Jaju; Khamis Al-Hashmi; Mohammed Al-Abri; Syed Rizvi; Riad Bayoumi
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

3.  High prevalence of diabetes in elderly of Iran: an urgent public health issue.

Authors:  Farid Fotouhi; Farhad Rezvan; Hassan Hashemi; Ali Javaherforoushzadeh; Mirgholamreza Mahbod; Abbasali Yekta; Zahra Jamshididana; Mehdi Khabazkhoob
Journal:  J Diabetes Metab Disord       Date:  2022-05-19

4.  Differences in cardiovascular risk profile of diabetic subjects discordantly classified by diagnostic criteria based on glycated hemoglobin and oral glucose tolerance test.

Authors:  Mauro Boronat; Pedro Saavedra; Laura López-Ríos; Marta Riaño; Ana M Wägner; Francisco J Nóvoa
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

5.  Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy.

Authors:  E Nelaj; M Gjata; I Lilaj; G Burazeri; E Sadiku; L Collaku; O Bare; M Tase
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

6.  Thyrotropin levels and their relationship with cardiovascular risk factors in the island of Gran Canaria, Spain. Implications of lowering the upper reference limit of thyrotropin stimulating hormone.

Authors:  M Alberiche; M Boronat; P Saavedra; N Pérez; D Marrero; Y López-Plasencia; V F Varillas; M Ríos; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

7.  High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: results of a cross-sectional epidemiological survey in Gran Canaria, Spain.

Authors:  Mauro Boronat; Pedro Saavedra; Nuria Pérez-Martín; María J López-Madrazo; Carlos Rodríguez-Pérez; Francisco J Nóvoa
Journal:  Cardiovasc Diabetol       Date:  2012-07-02       Impact factor: 9.951

8.  North African influences and potential bias in case-control association studies in the Spanish population.

Authors:  María Pino-Yanes; Almudena Corrales; Santiago Basaldúa; Alexis Hernández; Luisa Guerra; Jesús Villar; Carlos Flores
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

9.  Interaction between cholesteryl ester transfer protein and hepatic lipase encoding genes and the risk of type 2 diabetes: results from the Telde study.

Authors:  Laura López-Ríos; Francisco J Nóvoa; Ricardo Chirino; Francisco Varillas; Mauro Boronat-Cortés; Ana M Wägner
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

10.  Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults.

Authors:  Ilhan Satman; Beyhan Omer; Yildiz Tutuncu; Sibel Kalaca; Selda Gedik; Nevin Dinccag; Kubilay Karsidag; Sema Genc; Aysegul Telci; Bulent Canbaz; Fulya Turker; Temel Yilmaz; Bekir Cakir; Jaakko Tuomilehto
Journal:  Eur J Epidemiol       Date:  2013-02-14       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.